IL268929A - Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes - Google Patents
Compositions purposefully selected comprising purified cannabinoids and/or purified terpenesInfo
- Publication number
- IL268929A IL268929A IL26892919A IL26892919A IL268929A IL 268929 A IL268929 A IL 268929A IL 26892919 A IL26892919 A IL 26892919A IL 26892919 A IL26892919 A IL 26892919A IL 268929 A IL268929 A IL 268929A
- Authority
- IL
- Israel
- Prior art keywords
- purified
- compositions
- terpenes
- cannabinoids
- purposefully selected
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762465688P | 2017-03-01 | 2017-03-01 | |
| US201762469415P | 2017-03-09 | 2017-03-09 | |
| US201762475153P | 2017-03-22 | 2017-03-22 | |
| US201762477990P | 2017-03-28 | 2017-03-28 | |
| US201762489360P | 2017-04-24 | 2017-04-24 | |
| US201762490567P | 2017-04-26 | 2017-04-26 | |
| US201762490465P | 2017-04-26 | 2017-04-26 | |
| US201762491160P | 2017-04-27 | 2017-04-27 | |
| US201762491175P | 2017-04-27 | 2017-04-27 | |
| US201762491899P | 2017-04-28 | 2017-04-28 | |
| US201762491980P | 2017-04-28 | 2017-04-28 | |
| US201762509651P | 2017-05-22 | 2017-05-22 | |
| US201762510229P | 2017-05-23 | 2017-05-23 | |
| US201762510660P | 2017-05-24 | 2017-05-24 | |
| US201762510672P | 2017-05-24 | 2017-05-24 | |
| US201762511218P | 2017-05-25 | 2017-05-25 | |
| US15/616,874 US20170266153A1 (en) | 2015-02-27 | 2017-06-07 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
| PCT/US2018/020440 WO2018160827A1 (fr) | 2017-03-01 | 2018-03-01 | Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL268929A true IL268929A (en) | 2019-10-31 |
Family
ID=63370542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL26892919A IL268929A (en) | 2017-03-01 | 2019-08-26 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3589129A4 (fr) |
| CN (1) | CN110582206A (fr) |
| AU (1) | AU2018227544A1 (fr) |
| BR (1) | BR112019018088A2 (fr) |
| CA (1) | CA3054690A1 (fr) |
| CO (1) | CO2019009413A2 (fr) |
| IL (1) | IL268929A (fr) |
| MX (1) | MX2019010370A (fr) |
| PE (1) | PE20200383A1 (fr) |
| WO (1) | WO2018160827A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3031123C (fr) | 2018-01-23 | 2023-11-07 | High Sierra Technologies, Inc. | Produits de cannabis modifies par l'enlevement des composes organiques volatils et l'ajout d'hydrocarbures insatures volatils |
| IL266151A (en) * | 2019-04-18 | 2019-07-31 | Kanabo Res Ltd | Dilute for the cannabinoid preparations |
| WO2021012044A1 (fr) | 2019-07-22 | 2021-01-28 | Canopy Growth Corporation | Cristallisation continue de cannabinoïdes dans un réacteur à cuve agitée |
| JP2023508257A (ja) * | 2019-11-26 | 2023-03-02 | ライコレッド リミテッド． | カンナビノイドおよびリコピンの抗炎症性の相乗的組み合わせ |
| EP4142929A4 (fr) * | 2020-04-29 | 2024-02-21 | Ligar Limited Partnership | Polymères à empreinte et procédés pour leur utilisation |
| US20230146330A1 (en) * | 2020-07-27 | 2023-05-11 | Canopy Growth Corporation | Methods of synthesizing cannabielsoin and analogs thereof |
| US20240342197A1 (en) * | 2021-01-29 | 2024-10-17 | The Johns Hopkins University | Limonene effects on tetrahydrocannabinol (thc)-induced anxiety |
| CN113368086B (zh) * | 2021-08-11 | 2021-12-03 | 龙麻(上海)医药研发有限责任公司 | 一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用 |
| WO2023245185A1 (fr) * | 2022-06-17 | 2023-12-21 | New Growth Brands, Inc. | Compositions comprenant des cannabinoïdes et leurs procédés de préparation et d'utilisation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102009019322A1 (de) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
| GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| TWI583374B (zh) * | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| WO2015074137A1 (fr) * | 2013-11-20 | 2015-05-28 | Mary Lynch | Compositions et méthodes de traitement de l'inflammation oculaire et de la douleur |
| BR112017018316A2 (pt) * | 2015-02-27 | 2018-04-17 | Ebbu Llc | composições compreendendo combinações de canabinoides purificados, com pelo menos um flavonoide, terpeno ou mineral |
-
2018
- 2018-03-01 MX MX2019010370A patent/MX2019010370A/es unknown
- 2018-03-01 CN CN201880028815.7A patent/CN110582206A/zh active Pending
- 2018-03-01 WO PCT/US2018/020440 patent/WO2018160827A1/fr unknown
- 2018-03-01 BR BR112019018088-5A patent/BR112019018088A2/pt not_active Application Discontinuation
- 2018-03-01 CA CA3054690A patent/CA3054690A1/fr active Pending
- 2018-03-01 EP EP18760302.2A patent/EP3589129A4/fr not_active Withdrawn
- 2018-03-01 AU AU2018227544A patent/AU2018227544A1/en not_active Abandoned
- 2018-03-01 PE PE2019001790A patent/PE20200383A1/es unknown
-
2019
- 2019-08-26 IL IL26892919A patent/IL268929A/en unknown
- 2019-08-29 CO CONC2019/0009413A patent/CO2019009413A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018227544A1 (en) | 2019-08-29 |
| CO2019009413A2 (es) | 2019-09-09 |
| PE20200383A1 (es) | 2020-02-24 |
| CN110582206A (zh) | 2019-12-17 |
| BR112019018088A2 (pt) | 2020-03-24 |
| CA3054690A1 (fr) | 2018-09-07 |
| MX2019010370A (es) | 2019-10-22 |
| WO2018160827A1 (fr) | 2018-09-07 |
| EP3589129A1 (fr) | 2020-01-08 |
| EP3589129A4 (fr) | 2020-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268929A (en) | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes | |
| IL286693A (en) | Combined stress response modulator compounds, preparations containing them and their uses | |
| IL263676A (en) | Methods and preparations for reducing oxidative stress | |
| IL254025B (en) | Compositions containing a mixture of pure cannabinoids with at least one flavonoid, terpene or mineral | |
| HK1251922A1 (zh) | 抗微生物組合物及其用途 | |
| EP3478308A4 (fr) | Composition à base de cannabis et procédés | |
| IL254012A0 (en) | The hemostatic composition and the hemostatic device (variants) | |
| IL271275A (en) | Preparations containing coronas and their uses | |
| IL270776A (en) | CBLB endonuclease variants, compositions and methods of use | |
| SG11202001725SA (en) | Synthetic cannabidiol compositions and methods of making the same | |
| SI3580561T1 (sl) | Metode, osnovane na hla, in njihove sestave ter uporabe | |
| EP3634390A4 (fr) | Compositions antimicrobiennes comprenant des cannabinoïdes et leurs méthodes d'utilisation | |
| IL279755A (en) | Senolytic preparations and their uses | |
| IL287929A (en) | Cannabinoids and their uses | |
| SG11201803669UA (en) | Microorganism-controlling agent and miticidal composition | |
| IL278881A (en) | Cannabinoids and their use | |
| IL283850A (en) | Cannabis compounds and methods | |
| GB201608762D0 (en) | Compositions and uses thereof | |
| IL273988A (en) | Compounds of cannabidiol and chitosan, and methods for their use | |
| EP3568203C0 (fr) | Composés et compositions | |
| GB201807576D0 (en) | Compositions and uses thereof | |
| IL277663A (en) | Arunumab preparations and their uses | |
| GB201821138D0 (en) | Compositions and uses thereof | |
| ZA201706950B (en) | Antibacterial compositions and methods | |
| GB201602409D0 (en) | Compositions and uses thereof |